JP2022552292A5 - - Google Patents

Info

Publication number
JP2022552292A5
JP2022552292A5 JP2022521324A JP2022521324A JP2022552292A5 JP 2022552292 A5 JP2022552292 A5 JP 2022552292A5 JP 2022521324 A JP2022521324 A JP 2022521324A JP 2022521324 A JP2022521324 A JP 2022521324A JP 2022552292 A5 JP2022552292 A5 JP 2022552292A5
Authority
JP
Japan
Prior art keywords
amino acid
blend preparation
dry blend
aqueous suspension
inventions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022521324A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022552292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/055068 external-priority patent/WO2021072259A1/en
Publication of JP2022552292A publication Critical patent/JP2022552292A/ja
Publication of JP2022552292A5 publication Critical patent/JP2022552292A5/ja
Pending legal-status Critical Current

Links

JP2022521324A 2019-10-10 2020-10-09 アミノ酸実体を含む低容積製剤 Pending JP2022552292A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962913515P 2019-10-10 2019-10-10
US201962913524P 2019-10-10 2019-10-10
US62/913,524 2019-10-10
US62/913,515 2019-10-10
PCT/US2020/055068 WO2021072259A1 (en) 2019-10-10 2020-10-09 Reduced volume formulations including amino acid entities

Publications (2)

Publication Number Publication Date
JP2022552292A JP2022552292A (ja) 2022-12-15
JP2022552292A5 true JP2022552292A5 (enExample) 2023-10-13

Family

ID=73040286

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022521324A Pending JP2022552292A (ja) 2019-10-10 2020-10-09 アミノ酸実体を含む低容積製剤

Country Status (15)

Country Link
US (1) US20210128466A1 (enExample)
EP (1) EP4040993A1 (enExample)
JP (1) JP2022552292A (enExample)
KR (1) KR20220077143A (enExample)
CN (1) CN114845572A (enExample)
AU (1) AU2020364067A1 (enExample)
BR (1) BR112022006296A2 (enExample)
CA (1) CA3156674A1 (enExample)
CL (1) CL2022000866A1 (enExample)
CO (1) CO2022004459A2 (enExample)
IL (1) IL291849A (enExample)
JO (1) JOP20220086A1 (enExample)
MX (1) MX2022004217A (enExample)
TW (1) TW202128031A (enExample)
WO (1) WO2021072259A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11737999B2 (en) 2021-07-26 2023-08-29 Axcella Health Inc. Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19
CN118609687B (zh) * 2024-07-25 2024-10-11 辽宁诺维诺制药股份有限公司 一种用于左卡尼汀合成的d-(-)-酒石酸制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
WO2002057154A1 (en) * 2001-01-16 2002-07-25 Ajava Pinata, Llc Suspended containers
ATE550074T1 (de) * 2004-09-02 2012-04-15 Janssen Pharmaceutica Nv Fumarat aus 4-((4-((4-(2-cyanoethenyl)-2,6- dimethylphenyl amino -2-pyrimidinyl amino benzonitril
WO2008130220A1 (en) * 2007-04-20 2008-10-30 N.V. Nutricia Process for dispersing amino acids
CN105287484A (zh) * 2007-11-30 2016-02-03 盖尔德马研究及发展公司 含有萘甲酸衍生物、过氧化苯甲酰和成膜剂的组合物
CA3055986C (en) * 2017-03-31 2025-09-16 J.R. Simplot Company POTATO PROTEIN POWDERS
US11142492B2 (en) * 2019-08-26 2021-10-12 Wisconsin Alumni Research Foundation Methods of isolating phenols from phenol-containing media

Similar Documents

Publication Publication Date Title
JP2911814B2 (ja) リポソーム性の水中分散する経口投与可能な固体乾燥治療用処方の製造方法
IL265561A (en) A solid composition containing iron for use in situations of iron deficiency
US7759394B2 (en) Diclofenac formulations and methods of use
KR20240001702A (ko) 지지된 니코틴 조성물
JP7444967B2 (ja) 4-アミノ-3-置換ブタン酸誘導体の安定化製剤
US20070231395A1 (en) Solid Pharmaceutical Preparation for Dialysis
US20250057773A1 (en) Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules
JP2018503686A (ja) レボドパおよびカルビドパ経腸用ゲル剤ならびに使用方法
KR20250134679A (ko) 라니피브라노르 제형
CN114845572A (zh) 包含氨基酸实体的体积减小的配制品
US20230330079A1 (en) Orally-disintegrating film comprising naratriptan
JP2001316265A (ja) オザグレルナトリウム含有注射液およびその安定化方法
JP7239604B2 (ja) 甲状腺ホルモンを含む吸入用の薬学的乾燥粉末組成物
JP2024510302A5 (enExample)
JPH07330612A (ja) メトクロプラミドおよびパラセタモールまたはアセチルサリチル酸誘導体を含有する粉末剤
JP2021104959A (ja) 錠剤
US20240325542A1 (en) Use of a phospholipid as a crystallization inhibitor
JP2007238491A (ja) 医薬製剤
BG3870U1 (bg) Гранули за перорален разтвор, съдържащи кетопрофен
WO2014009805A1 (en) Liquid compositions comprising iron for use in the treatment of disorders or diseases related to an iron deficiency
JP2002322061A (ja) プロカテロールドライシロップ製剤
BG113179A (bg) Гранули за перорален разтвор, съдържащи кетопрофен и метод за тяхното получаване
EA042077B1 (ru) Сухая порошкообразная фармацевтическая композиция для ингаляции, содержащая тиреоидный гормон
IX GATTI G.," BARZAGHI N.," ATTARDO PARRINELLO G.," VITIELLO B., º PERUCCA E.
BG66613B1 (bg) Прахообразен фармацевтичен състав, съдържащ метамизол